SODIUM CHLORIDE- normal salt tablets tablet 
Wittman Pharma, Inc.

----------

Sodium Chloride Tablets

Directions

Warnings

Do not use without consulting a physician

Ask a physician before use if you have a sodium restricted diet due to multiple organ diseases

Stop use and ask a physician if symptoms of heat cramps continue for more than 24 hours.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

None

Uses

Keep out of reach of children.

Purpose

Electrolyte Replenisher

Active ingredient (in each tablet)

Sodium Chloride, USP 1.0 gram

Drug Facts

Active ingredient (in each tablet)

Sodium Chloride, USP 1.0 gram

Purpose

Electrolyte Replenisher

Uses

Warnings

Do not use without consulting a physician

Ask a physician before use if you have a sodium restricted diet due to multiple organ diseases

Stop use and ask a physician if symptoms of heat cramps continue for more than 24 hours.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Other information

Questions or comments?

Call 1-352-549-9917 M-F 9am - 5pm EST

Salt Label

SODIUM CHLORIDE 
normal salt tablets tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83335-002
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE1 g  in 1 g
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize12mm
FlavorImprint Code SC
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83335-002-01100 g in 1 BOTTLE; Type 0: Not a Combination Product08/09/2023
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)08/09/2023
Labeler - Wittman Pharma, Inc. (830980947)
Registrant - Wittman Pharma, Inc. (830980947)
Establishment
NameAddressID/FEIBusiness Operations
Wittman Pharma, Inc.830980947label(83335-002) , analysis(83335-002) , manufacture(83335-002)

Revised: 4/2024
Document Id: 154806ed-91ac-fc7f-e063-6294a90ae0f4
Set id: 027fd7db-c06f-3245-e063-6294a90af540
Version: 3
Effective Time: 20240404
 
Wittman Pharma, Inc.